SARS-CoV-2 S1-RBD Antibodies

The SARS-CoV-2 S1-RBD Antibodies test specifically detects antibodies targeting the receptor-binding domain (RBD) of the spike protein (S1) of the virus. This test provides detailed information about the immune response to SARS-CoV-2, aiding in the assessment of past infection or vaccine-induced immunity.